Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans

Diabetologia

Volumn 54, Issue 5, 2011, Pages 1200-1211

  Friebe, D ^a   Neef, M ^a   Kratzsch, J ^b   Erbs, S ^b   Dittrich, K ^a   Garten, A ^a   Petzold Quinque, S ^a   Bluher S ^a   Reinehr, T ^c   Stumvoll, M ^a,b   Bluher M ^a,b   Kiess, W ^a   Korner A ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Adipocytokines; Children; Glucose metabolism; Insulin sensitivity; NAMPT; Obesity; PBEF; Visfatin

Indexed keywords

C REACTIVE PROTEIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CHILD; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SYNTHESIS; EXERCISE; GLUCOSE METABOLISM; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; LEAN BODY WEIGHT; LEUKOCYTE; LEUKOCYTE COUNT; LIFESTYLE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONOCYTE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; BODY MASS INDEX; CHILD; EXERCISE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; SIRTUIN 1;

EID: 79954634068     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-2042-z     Document Type: Article

References (49)

1. B Samal Y Sun G Stearns C Xie S Suggs I McNiece 1994 Cloning and characterization of the cDNA encoding a novel human pre-B cell colony-enhancing factor Mol Cell Biol 14 1431 1437 8289818 1:CAS:528:DyaK2cXhvV2gsbw%3D
2. A Fukuhara M Matsuda M Nishizawa, et al. 2005 Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 426 430 15604363 10.1126/science.1097243 1:CAS:528:DC%2BD2MXksFyitw%3D%3D (Pubitemid 40139988)
3. JR Revollo AA Grimm S Imai 2004 The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells J Biol Chem 279 50754 50763 15381699 10.1074/jbc.M408388200 1:CAS:528:DC%2BD2cXhtVaru7vL (Pubitemid 40017813)
4. A Garten S Petzold A Körner S Imai W Kiess 2009 Nampt: linking NAD biology, metabolism and cancer Trends Endocrinol Metab 20 130 138 19109034 10.1016/j.tem.2008.10.004 1:CAS:528:DC%2BD1MXjsFanu7o%3D
5. JR Revollo A Körner KF Mills, et al. 2007 Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab 6 363 375 17983582 10.1016/j.cmet.2007.09.003 1:CAS:528: DC%2BD2sXhtlemsr%2FJ (Pubitemid 350011996)
6. W Kiess S Petzold M Töpfer, et al. 2008 Adipocytes and adipose tissue Best Pract Res Clin Endocrinol Metab 22 135 153 18279785 10.1016/j.beem.2007.10.002 1:CAS:528:DC%2BD1cXitVKnsLs%3D (Pubitemid 351222159)
7. J Berndt N Klöting S Kralisch, et al. 2005 Plasma visfatin concentrations and fat depot-specific mRNA expression in humans Diabetes 54 2911 2916 16186392 10.2337/diabetes.54.10.2911 1:CAS:528:DC%2BD2MXhtV2rs7%2FN (Pubitemid 41401086)
8. DG Haider K Schindler G Schaller G Prager M Wolzt B Ludvik 2006 Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding J Clin Endocrinol Metab 91 1578 1581 16449335 10.1210/jc.2005-2248 1:CAS:528:DC%2BD28XjvFOktLk%3D
9. E Ingelsson MG Larson CS Fox, et al. 2007 Clinical correlates of circulating visfatin levels in a community-based sample Diabetes Care 30 1278 1280 17261750 10.2337/dc06-2353 1:CAS:528:DC%2BD2sXmtFKmsr8%3D (Pubitemid 46684663)
10. R Retnakaran BS Youn Y Liu, et al. 2008 Correlation of circulating full-length visfatin (PBEF/NAMPT) with metabolic variables in subjects with and without diabetes: a cross-sectional study Clin Endocrinol Oxf 69 885 893 18410550 10.1111/j.1365-2265.2008.03264.x 1:CAS:528:DC%2BD1MXmtlOitw%3D%3D
11. CA Curat V Wegner C Sengenes, et al. 2006 Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin Diabetologia 49 744 747 16496121 10.1007/s00125-006-0173-z 1:CAS:528:DC%2BD28XitF2jtrc%3D (Pubitemid 43357549)
12. A Garten S Petzold A Barnikol-Oettler, et al. 2010 Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is constitutively released from human hepatocytes Biochem Biophys Res Commun 391 376 381 19912992 10.1016/j.bbrc.2009.11.066 1:CAS:528:DC%2BC3cXpsVWj
13. S Imai 2009 SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty Curr Opin Clin Nutr Metab Care 12 350 356 19474721 10.1097/MCO.0b013e32832c932d 1:CAS:528:DC%2BD1MXnt1Oqt7k%3D
14. S Imai 2009 The NAD World: a new systemic regulatory network for metabolism and aging-Sirt1, systemic NAD biosynthesis, and their importance Cell Biochem Biophys 53 65 74 19130305 10.1007/s12013-008-9041-4 1:CAS:528:DC%2BD1MXhtlOksrs%3D
15. DG Haider G Holzer G Schaller, et al. 2006 The adipokine visfatin is markedly elevated in obese children J Pediatr Gastroenterol Nutr 43 548 549 17033537 10.1097/01.mpg.0000235749.50820.b3 1:CAS:528:DC%2BD28XhtVKjtLvL (Pubitemid 44569022)
16. H Jin B Jiang J Tang, et al. 2008 Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol Diab Res Clin Pract 79 412 418 10.1016/j.diabres.2007.09.019 1:CAS:528:DC%2BD1cXisVWgu7s%3D
17. A Reich G Müller G Gelbrich K Deutscher R Godicke W Kiess 2003 Obesity and blood pressure-results from the examination of 2365 schoolchildren in Germany Int J Obes Relat Metab Disord 27 1459 1464 14634675 10.1038/sj.ijo.0802462 1:STN:280:DC%2BD3srlsVWquw%3D%3D (Pubitemid 38019157)
18. A Böttner J Kratzsch G Muller, et al. 2004 Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels J Clin Endocrinol Metab 89 4053 4061 15292348 10.1210/jc.2004-0303 (Pubitemid 39071513)
19. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 419 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
20. M Matsuda RA DeFronzo 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diabetes Care 22 1462 1470 10480510 10.2337/diacare.22.9.1462 1:STN:280:DyaK1MvgvVertQ%3D%3D (Pubitemid 29418240)
21. Friebe D, Neef M, Erbs S et al (2011) Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes. doi: 10.3109/17477166.2010.491228
22. T Reinehr G de Sousa AM Toschke W Andler 2006 Long-term follow-up of cardiovascular disease risk factors in children after an obesity intervention Am J Clin Nutr 84 490 496 16960161 1:CAS:528:DC%2BD28XpvVCqt7c%3D (Pubitemid 44713397)
23. M Fried V Hainer A Basdevant, et al. 2008 Interdisciplinary European guidelines on surgery of severe obesity Obes Facts 1 52 59 20054163 10.1159/000113937
24. TH Inge NF Krebs VF Garcia, et al. 2004 Bariatric surgery for severely overweight adolescents: concerns and recommendations Pediatrics 114 217 223 15231931 10.1542/peds.114.1.217 (Pubitemid 38857589)
25. K Kromeyer-Hauschild M Wabitsch FJ Geller, et al. 2001 Perzentilen für den Body Mass Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben [Centiles for body mass index for children and adolescents derived from distinct independent German cohorts] Monatsschr Kinderheilkd 149 807 818 10.1007/s001120170107 (Pubitemid 32830649)
26. N Krankel V Adams A Linke, et al. 2005 Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells Arterioscler Thromb Vasc Biol 25 698 703 15662022 10.1161/01.ATV.0000156401.04325.8f (Pubitemid 40463856)
27. A Körner A Garten M Bluher R Tauscher J Kratzsch W Kiess 2007 Molecular characteristics of serum visfatin and differential detection by immunoassays J Clin Endocrinol Metab 92 4783 4791 17878256 10.1210/jc.2007-1304 (Pubitemid 350223461)
28. GC Elliott J Ajioka CY Okada 1980 A rapid procedure for assaying nicotinamide phosphoribosyltransferase Anal Biochem 107 199 205 6449162 10.1016/0003-2697(80)90512-6 1:CAS:528:DyaL3cXlvVWlsb4%3D (Pubitemid 11196643)
29. S Bo G Ciccone I Baldi, et al. 2009 Plasma visfatin concentrations after a lifestyle intervention were directly associated with inflammatory markers Nutr Metab Cardiovasc Dis 19 423 430 19073361 10.1016/j.numecd.2008.09.001 1:STN:280:DC%2BD1MvjsVequg%3D%3D
30. I Brema M Hatunic F Finucane, et al. 2008 Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus Diab Obes Metab 10 600 602 10.1111/j.1463-1326.2008.00872.x 1:STN:280:DC%2BD1cvgvFSisQ%3D%3D (Pubitemid 351850905)
31. DG Haider G Schaller S Kapiotis C Maier A Luger M Wolzt 2006 The release of the adipocytokine visfatin is regulated by glucose and insulin Diabetologia 49 1909 1914 16736128 10.1007/s00125-006-0303-7 1:CAS:528:DC%2BD28Xms1Oisb0%3D (Pubitemid 44025046)
32. D Hofso T Ueland H Hager, et al. 2009 Inflammatory mediators in morbidly obese subjects: associations with glucose abnormalities and changes after oral glucose Eur J Endocrinol 161 451 458 19542241 10.1530/EJE-09-0421
33. L Li G Yang Q Li, et al. 2006 Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects Exp Clin Endocrinol Diab 114 544 548 10.1055/s-2006-948309 1:CAS:528:DC%2BD2sXms1Gktw%3D%3D (Pubitemid 46087259)
34. + salvage pathway by CLOCK-SIRT1 Science 324 654 657 19286518 10.1126/science.1170803 1:CAS:528:DC%2BD1MXltFCisL8%3D
35. + biosynthesis Science 324 651 654 19299583 10.1126/science.1171641 1:CAS:528:DC%2BD1MXltFCis7c%3D
36. MP Chen FM Chung DM Chang, et al. 2006 Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 91 295 299 16234302 10.1210/jc.2005-1475 1:CAS:528:DC%2BD28Xms1alsA%3D%3D (Pubitemid 43069152)
37. SV de Kreutzenberg G Ceolotto I Papparella, et al. 2010 Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms Diabetes 59 1006 1015 20068143 10.2337/db09-1187
38. M Orimo T Minamino H Miyauchi, et al. 2009 Protective role of SIRT1 in diabetic vascular dysfunction Arterioscler Thromb Vasc Biol 29 889 894 19286634 10.1161/ATVBAHA.109.185694 1:CAS:528:DC%2BD1MXlslCgtbc%3D
39. JN Fain BM Tagele P Cheema AK Madan DS Tichansky 2010 Release of 12 adipokines by adipose tissue, nonfat cells, and fat cells from obese women Obes Silver Spring 18 890 896 10.1038/oby.2009.335 1:CAS:528:DC%2BC3cXlt1ahtro%3D
40. M Visser LM Bouter GM McQuillan MH Wener TB Harris 2001 Low-grade systemic inflammation in overweight children Pediatrics 107 E13 11134477 10.1542/peds.107.1.e13 1:STN:280:DC%2BD3M%2FpsVaisQ%3D%3D
41. F Zaldivar RG McMurray D Nemet P Galassetti PJ Mills DM Cooper 2006 Body fat and circulating leucocytes in children Int J Obes Lond 30 906 911 16418751 10.1038/sj.ijo.0803227 1:STN:280:DC%2BD28zgtlWksg%3D%3D (Pubitemid 43801189)
42. JA Seo ES Jang BG Kim, et al. 2008 Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women Diab Res Clin Pract 79 108 111 10.1016/j.diabres.2007.04.016 1:CAS:528:DC%2BD1cXisFKqsQ%3D%3D
43. TH Mayi C Duhem C Copin, et al. 2010 Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages FEBS J 277 3308 3320 20608974
44. J Skokowa D Lan BK Thakur, et al. 2009 NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway Nat Med 15 151 158 19182797 10.1038/nm.1913 1:CAS:528:DC%2BD1MXht1ehu7s%3D
45. KJ Lee YA Shin KY Lee TW Jun W Song 2010 Aerobic exercise training-induced decrease in plasma visfatin and insulin resistance in obese female adolescents Int J Sport Nutr Exerc Metab 20 275 281 20739715 1:CAS:528:DC%2BC3cXhsFyhur3L
46. R von Kanel PJ Mills JE Dimsdale 2001 Short-term hyperglycemia induces lymphopenia and lymphocyte subset redistribution Life Sci 69 255 262 10.1016/S0024-3205(01)01127-4 (Pubitemid 32601911)
47. YS Kang HK Song MH Lee GJ Ko DR Cha 2010 Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patients Diab Res Clin Pract 89 141 149 10.1016/j.diabres.2010.03.020 1:CAS:528:DC%2BC3cXptlaht7c%3D
48. Catalan V, Gomez-Ambrosi J, Rodriguez A et al (2011) Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity. Nutr Metab Cardiovasc Dis. doi: 10.1016/j.numecd.2009.09.008
49. B Mesko S Poliska A Szegedi, et al. 2010 Peripheral blood gene expression patterns discriminate among chronic inflammatory diseases and healthy controls and identify novel targets BMC Med Genomics 3 15 20444268 10.1186/1755-8794-3-15